Navigation Links
GATC Biotech AG is investing more than 5 million euros in its Constance site to double the company's floor space

Constance, September 10, 2009 / b3c newswire / - The mayor Claus Boldt, together with architect Hans-Peter Engelmann and CEO Peter Pohl, officially turned the first sod, thus marking the beginning of the expansion the Constance site of GATC Biotech, Europe's leading sequencing service provider.

The company will invest more than 5 million euros in its Constance headquarters until 2012 to create offices and laboratories for an additional 100 employees.

An extra 960 square meters will more than double the existing laboratory and office space. The three-storey annex will be directly attached to the original building. A glass atrium will connect the old and the new buildings. The architect's office Giel & Engelmann in Constance is responsible for planning and construction supervision.

"Because of our company's strong growth over the last few years, we are in dire need of a new building. We are literally bursting at the seams as we have more than doubled the number of our employees since 2006. Furthermore, we urgently need further laboratory space in order to expand our sequencing capacity to 30 terabases until 2013. This increase in capacity is required to enable us to advance our international expansion plans. We are very proud that we are able to create and secure jobs even in economically difficult times and to strengthen and further expand the dynamic life science hub at Lake Constance," says Peter Pohl.

The inauguration of the annex in spring 2010 will coincide with GATCs 20th anniversary. You can follow the construction works live at

About GATC Biotech -
GATC Biotech is Europes leading service provider of DNA sequencing and bioinformatics for industry and academic research. For nearly two decades we have been continuously developing new and comprehensive solutions for DNA sequencing and bioinformatics sequence analysis for individual DNA samples through to whole transcriptome and genome projects. With a total of eleven sequencing instruments (ABI 3730xl, Illumina Genome Analyzer IIx, Roche GS FLX) GATC has the largest commercially available sequencing capacity in Europe with two terabases per year. The company is the first sequencing service provider in Germany to have completed the Illumina CSPro certification process. More than 100 employees serve over 10,000 customers in 40 countries around the globe. The company has subsidiary companies in Great Britain, France and Sweden.


GATC Biotech AG
Elke Decker
Jakob-Stadler-Platz 7
D-78467 Konstanz

Phone: (0) 7531-816030
Fax: (0) 7531-816081

b3c newswire

Related biology news :

1. Anti-biotech groups obstruct forest biotechnology
2. GenWay Biotech obtains exclusive rights to AMDLs DR-70 cancer test in US and Canada
3. Genome sequencing of fungus with biotechnological applications
4. Biotech scientists team with curators to stem decay of worlds art, cultural heritage
5. Genetic Engineering & Biotechnology News reports on the trend toward predictive toxicogenomics
6. Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics
7. CU-Boulder, biotech firm team up on python project in search for human cardiac therapeutics
8. Genetic Engineering & Biotechnology News reports on novel hit-to-lead drug discovery
9. Biotechnology key to developing sustainable industries says international panel
10. Genetic Engineering & Biotechnology News reports on growing use of cell-based assays
11. Food biotechnology: real world challenges
Post Your Comments:
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( ) will also ... by the use of DNA technology to an industry ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... Calif. , June 23, 2016  The Prostate Cancer Foundation ... increasingly precise treatments and faster cures for prostate cancer. Members of the Class ... across 15 countries. Read More About the Class of ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published ... how a patient who developed lymphedema after being treated for breast cancer benefitted from ... the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only ... Center and will showcase its product’s latest features from June 26 to June ... scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
Breaking Biology Technology: